EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

New England Journal of Medicine - Tập 352 Số 8 - Trang 786-792 - 2005
Susumu Kobayashi1, Titus J. Boggon2,3, Tajhal Dayaram1, Pasi A. Jänne4,5, Olivier Kocher6, Matthew Meyerson5,7, Bruce E. Johnson4,5, Michael J. Eck2,3, Daniel G. Tenen1, Balázs Halmos1,8
1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School
2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
3Departments of Cancer Biology, Dana–Farber Cancer Institute, Harvard Medical School
4Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
5Medical Oncology, Dana–Farber Cancer Institute, Harvard Medical School
6Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School
7Pathology, Dana–Farber Cancer Institute, Harvard Medical School
8Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.54.1.8

10.1056/NEJMoa011954

10.1200/JCO.2002.02.068

10.1200/JCO.2003.01.504

10.1200/JCO.2003.10.038

10.1001/jama.290.16.2149

10.1200/JCO.2004.11.057

10.1200/JCO.2004.08.158

10.1056/NEJMoa040938

10.1126/science.1099314

10.1073/pnas.0405220101

10.1126/science.1101637

10.1200/JCO.2005.07.169

10.1074/jbc.M207135200

10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B

10.1107/S0907444904011679

10.1016/S0006-2952(98)00356-6

10.1126/science.1062538

10.1158/0008-5472.CAN-04-0085

10.1016/S0092-8674(03)00190-9

10.1126/science.1099480

10.1074/jbc.M211158200

10.1200/JCO.20.1.110

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 352 Số 8

786-792

Thông tin tác giả